ANI Pharmaceuticals Reports First Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Strong AI earnings lift S&P 500, Nasdaq as inflation data calms rate-hike jitters
- Oil prices little changed as investors weigh lower demand against US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
ANI Pharma (ANIP) Tops Q1 EPS by 33c, Revenues Beat
May 7, 2021 6:52 AM EDTANI Pharma (NASDAQ: ANIP) reported Q1 EPS of $1.04, $0.33 better than the analyst estimate of $0.71. Revenue for the quarter came in at $54.5 million versus the consensus estimate of $46.8 million.
First Quarter 2021 Financial Highlights:
Net revenues were $54.5 million compared to $49.8 million in Q1 2020.GAAP net income was $0.1 million, and diluted GAAP earnings per share was $0.01.Adjusted non-GAAP EBITDA was $18.9 million.Adjusted non-GAAP diluted earnings per share was $1.04.Cash and cash equivalents were $25.1 million, net accounts receivable was $91.9 million,... More
